How Recent Rallies Stack Up Against Valuations

January 11, 2026 at 07:09 UTC

4 min read

Stock valuation comparison chart showing recent rally impact on top equities

Key Points

Several high‑profile stocks have surged, prompting fresh questions on value.
DCF models flag large undervaluation gaps for names like Novartis, GSK and Adobe.
Other winners, including ASML and Microchip, now screen as overvalued on key metrics.
Mixed signals between DCF and multiples highlight how sensitive valuations are to assumptions.

Strong price moves trigger valuation reassessments

Across sectors, a series of sharp share price moves is drawing renewed scrutiny of valuations. Pharmaceutical group Novartis, gold producer Centerra Gold, aluminum producer Alcoa, software company Adobe and healthcare group GSK have all delivered sizeable gains over the past year, while names such as Herbalife and Sandisk have seen triple‑digit or near‑triple‑digit advances over shorter periods. At the same time, companies like Six Flags Entertainment, TaskUs and Under Armour have experienced notable declines over one or more years, even as some of them have rebounded in recent weeks. These contrasting trajectories are prompting investors to compare current prices with a range of valuation models, including discounted cash flow (DCF) estimates and earnings or sales multiples, to judge whether recent momentum is supported by fundamentals.

DCF models point to wide discounts at several large caps

The latest DCF work from Simply Wall St suggests substantial implied upside for a number of established companies despite recent gains. Novartis is estimated to have an intrinsic value of about CHF 263.87 per share versus a market price near CHF 114.04, implying it screens as undervalued by 56.8% on that model. GSK’s DCF output indicates a value of £43.59 per share against a price around £18.86, a 56.7% gap. Adobe’s intrinsic value is put at US$522.29 per share compared with a recent US$333.95, a 36.1% discount, while Alcoa’s DCF value of US$203.34 versus US$63.67 implies a 68.7% discount even after an approximately 80% one‑year share price rise. Other names showing large DCF discounts include Equinix (38.4% below an estimated US$1,299.32 value), Centerra Gold (39.0% below CA$35.06), Herbalife (35.9% below US$23.36), eBay (19.5% below US$112.98), Macy’s (19.3% below US$28.69), TaskUs (69.5% below US$38.96), Six Flags Entertainment (72.8% below US$58.50) and Altria Group (45.5% below US$105.52). In each case, the models use a two‑stage free cash flow to equity approach based on recent free cash flow and analyst projections extended out to around 2030–2035.

Multiples and Fair Ratios offer a contrasting lens

Valuation checks based on price‑to‑earnings (P/E) or price‑to‑sales (P/S) ratios sometimes reinforce, and sometimes contradict, the DCF signals. Novartis trades on a P/E of 19.0x, below both the pharmaceuticals industry average of about 23.0x and a peer average of 86.3x, and also below Simply Wall St’s Fair Ratio estimate of 37.3x, supporting an undervaluation view. GSK’s 13.8x P/E sits under its industry and peer averages and below a Fair Ratio of 26.1x. Adobe’s 19.61x P/E is well under a 34.68x Fair Ratio, while Alcoa’s 14.73x P/E is below both sector averages and its 16.93x Fair Ratio. Similar patterns appear at Altria (10.92x vs a 18.55x Fair Ratio), Centerra Gold (9.16x vs 14.04x), Macy’s (12.92x vs 15.89x) and TaskUs (13.18x vs 20.01x). By contrast, Sandisk’s P/S of 7.11x is almost double its 3.62x Fair Ratio, and Microchip Technology’s 9.65x P/S exceeds an 8.76x Fair Ratio, with both stocks flagged as overvalued on these metrics. ASML Holding’s DCF analysis also suggests it may be overvalued by 37.7%, with an intrinsic value of €925.01 per share versus a US$1,273.88 price. Commvault Systems, meanwhile, is judged broadly fairly valued on DCF, with an intrinsic value of US$127.52 close to its US$124.17 share price, but its 68.24x P/E stands well above a 33.87x Fair Ratio, indicating an expensive earnings multiple.

Mixed signals underline the role of assumptions and narratives

Several companies show how different methods can yield opposing conclusions. Under Armour’s DCF workup produces an intrinsic value of US$4.38 per share versus a US$5.64 price, implying it may be 28.7% overvalued on that basis, yet its 0.47x P/S sits below both industry and peer averages and under a 0.93x Fair Ratio, suggesting undervaluation on sales. Equinix’s DCF points to a 38.4% discount to intrinsic value, while its 73.37x P/E is more than double a 35.91x Fair Ratio, screening as overvalued on earnings. Six Flags Entertainment trades on a P/S of 0.52x, below a 0.92x Fair Ratio and industry averages, and earns a 5/6 value score despite a recent 65.6% one‑year share price decline and negative trailing free cash flow. Bank of New York Mellon and American Express illustrate cases where excess‑returns or Fair Ratio models suggest prices are close to intrinsic value, even after multi‑year rallies. Across these examples, Simply Wall St highlights that its valuation scores, Fair Ratios and community “Narratives” are designed to help investors link their own assumptions on growth, margins and risk to explicit fair value estimates that can be compared with current market prices.

Key Takeaways

DCF models currently flag large implied discounts for several established companies, even where share prices have already rallied strongly.
Earnings and sales multiples, adjusted via Fair Ratios, often support those discounts but can also contradict DCF outputs for the same stock.
Cases like Equinix, Under Armour and Commvault show that valuation conclusions depend heavily on which metric and assumptions investors prioritise.